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Abstract
Activation of Notch1 signaling in neural progenitor cells (NPCs) induces self-renewal and inhibits neurogenesis. Upon
neuronal differentiation, NPCs overcome this inhibition, express proneural genes to induce Notch ligands, and activate
Notch1 in neighboring NPCs. The molecular mechanism that coordinates Notch1 inactivation with initiation of neurogenesis
remains elusive. Here, we provide evidence that Prox1, a transcription repressor and downstream target of proneural genes,
counteracts Notch1 signaling via direct suppression of Notch1 gene expression. By expression studies in the developing
spinal cord of chick and mouse embryo, we showed that Prox1 is limited to neuronal precursors residing between the
Notch1+ NPCs and post-mitotic neurons. Physiological levels of Prox1 in this tissue are sufficient to allow binding at Notch1
promoter and they are critical for proper Notch1 transcriptional regulation in vivo. Gain-of-function studies in the chick
neural tube and mouse NPCs suggest that Prox1-mediated suppression of Notch1 relieves its inhibition on neurogenesis
and allows NPCs to exit the cell cycle and differentiate. Moreover, loss-of-function in the chick neural tube shows that Prox1
is necessary for suppression of Notch1 outside the ventricular zone, inhibition of active Notch signaling, down-regulation of
NPC markers, and completion of neuronal differentiation program. Together these data suggest that Prox1 inhibits Notch1
gene expression to control the balance between NPC self-renewal and neuronal differentiation.
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Introduction
Notch1 signaling plays an important role in the maintenance of
NPCs in the undifferentiated state by inhibiting neuronal
differentiation [1–3]. In the developing nervous system, NPCs
initially undergo symmetric divisions to expand the available pool
of progenitor cells, while at later stages, during the neurogenic
phase, they switch to asymmetric divisions generating one
progenitor cell and one neuronal precursor destined to become
a neuron. In these nascent neurons, proneural genes induce the
expression of Notch ligands such as Delta1 and Jagged, which in
turn activate Notch1 in neighboring NPCs. The interaction of
Notch1 with its ligands results in cleavage of the Notch
intracellular domain (NICD) by the presenilin/c-secretase com-
plex [4] and its translocation to the nucleus where it forms a
complex with RBP-J (CBF1). This complex activates transcription
of the basic helix-loop-helix (bHLH) genes Hes1 and Hes5, which
act as downstream effectors of Notch1 to down-regulate proneural
gene expression and inhibit neurogenesis [5–9]. By this process,
also known as lateral inhibition, newly produced neurons are
thought to feedback and inhibit neighboring NPCs from
differentiating, thus regulating the number of neurons born at a
given time and maintaining a pool of NPCs for generation of
subsequent neurons and glia. However, in these asymmetrically
produced precursors that have been instructed to become post-
mitotic neurons, active Notch1 signaling has to be terminated
[2,10]. Although the reduced expression of Notch1 ligands by
neighboring cells contributes to a decrease in Notch1 signaling,
additional mechanisms should operate to protect nascent neuronal
precursors against Notch1 signals from neighboring cells and
maintain neuronal fate and specification. In vertebrate CNS the
molecular mechanism that inactivates Notch1 signaling in cells
destined to become neurons during the initial phases of
differentiation remains largely unknown [10].
To this end, we hypothesized that proneural genes, which are
expressed into the Notch1 positive area in the neural tube [5], may
activate downstream effector genes that will coordinate cell-
autonomously the induction of neuronal differentiation with the
inhibition of Notch1 signaling. In this regard two possible
mechanisms, non-mutually exclusive, may be envisaged: either
inactivation of key component(s) in the Notch1 signaling axis via
protein-protein interactions and/or degradation, or down-regula-
tion by transcriptional repression. Detailed expression studies have
previously shown that newly-born neurons readily down-regulate
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ventricular zone (VZ) rapidly suppress Notch1 gene expression [11–
13]. This observation indicates that a potential mechanism,
operating in neuronal precursors to desensitize them from
responding to Delta/Jagged signal-sending cells, is to down-
regulate the expression of the Notch1 itself by transcriptional
repression.
Prox1, a homeobox transcription repressor, acting downstream
of proneural genes during neurogenesis, is a good candidate for
such a function. Interestingly, Prospero, the Drosophila homologue of
Prox1 in vertebrates, is a critical regulator of the balance between
self-renewal and differentiation in neural stem cells (NSCs)
[14,15]. Prospero suppresses the genetic program for self-renewal
of NSCs and cell cycle progression, while it activates genes for
terminal neuronal differentiation [15,16]. Neuroblasts that lack
Prospero form tumors in the embryonic nervous system of
Drosophila [15]. Notch signaling appears to have the opposite
function by promoting self-renewal and neuroblast identity [17–
19]. Most important, Prox1 in vertebrates is expressed in the
boundaries between Notch1+ and Notch12 cells during develop-
ment of the spinal cord and is transiently expressed in neuronal
precursors but not in terminally differentiated neurons in this
region [20–22]. Multiple lines of evidence suggest important roles
for Prox1 in different aspects of embryonic development and
morphogenesis, while mouse embryos deficient in Prox1 die at
E14.5, a critical time point in the development of many different
organs [23,24]. Thus, Prox1 has been previously shown to have
essential roles during lymphatic, hepatocyte, pancreatic, heart,
lens, retinal, and spinal cord development [20,23,25–29].
Collectively, these observations indicate that Prox1 is involved in
many key developmental decisions during organ morphogenesis.
Here we provide functional evidence that Prox1 is directly
implicated in Notch1 gene suppression during neurogenesis in the
developing spinal cord and thus co-ordinately regulates Notch1
signaling inactivation with neuronal differentiation. In particular,
we showed that physiological levels of endogenous Prox1 are
sufficient to allow binding at the Notch1 promoter locus in vivo, and
gain-and-loss-of-function studies suggest that Prox1 levels are
essential for proper regulation of the endogenous Notch1 gene in
vivo. Moreover, these studies indicate that Prox1-mediated Notch1
suppression controls cell cycle exit and differentiation of NPCs.
Together our data imply that Prox1 is involved in the transition of
NPCs from self-renewal to neuronal differentiation via direct
suppression of Notch1.
Results
Prox1 Is Expressed in an Intermediate Zone between
Notch1+ Cells and Post-Mitotic Neurons in the Early
Spinal Cord
There is an inverse spatiotemporal correlation between
expression of Notch1 and neuronal markers such as SCG10,i na
way that differentiated neurons expressing SCG10 appear later in
development and localize in the mantle zone (MZ), whereas Notch1
and Hes5 are highly expressed early in development while later
reduced and detected in NPCs of the VZ (Figure 1A, 1B, 1D, 1E,
1G, 1H and unpublished data) [11–13]. Moreover, an interme-
diate zone of cells, negative for both markers, is also evident. These
observations suggest that prior to acquisition of a terminally
differentiated neuronal character the expression of Notch1 mRNA
has to be strongly down-regulated. However, the molecular
mechanism that actively directs suppression of Notch1 expression
to relieve its inhibitory action on neurogenesis remains totally
unknown. As Prox1 acts downstream of proneural genes and given
the inverse correlation between proneural genes and active Notch1
signaling, we considered Prox1 as a potential factor that could be
involved in this suppression. Comparative analysis of Prox1, Notch1,
and SCG10 expression by single and double in situ hybridization
revealed that Prox1 is expressed in the intermediate zone of cells
between Notch1+ NPCs and SCG10+ post-mitotic neurons (Figure
1 and Figure S1). Most important, Prox1 positive signal is observed
in a cell population that laminates and demarcates the area of
Notch1+ cells, both in the chick and mouse embryonic spinal cord
(Figure 1J, 1K, 1N, 1O and Figure S1Q–S1T), probably marking
a transitory cell population in the medio-lateral axis, that migrates
towards the MZ to differentiate into post-mitotic neurons (Figure
1R). This expression pattern is consistent with a role in suppressing
Notch1 expression at the mRNA level.
Prox1 Is Directly Involved in Notch1 Gene Suppression
To initially test this hypothesis, we performed transcriptional
assays in mouse neuroblastoma Neuro2A cells (N2A). We first used
previously published promoter-luciferase constructs for mamma-
lian Notch1 [30] or Hes1 and Hes5 genes [31,32] to evaluate the
effect of Prox1 on transcription regulation. After transient
transfections of N2A with a mouse (Figure 2A) or human (Figure
S2A) Prox1 expression vector, the activity of Notch1 promoter was
significantly decreased, whereas a control construct carrying the
human Thymidine-kinase (TK) promoter remained unaffected.
Prox1 was also able to suppress the activities of Hes1 and Hes5
promoters, presumably via its action on Notch1 (Figure 2A). To
determine whether Prox1 affects in a similar manner the
expression of endogenous genes, we stably overexpressed Prox1
in N2A. These cells showed reduced levels of Notch1 mRNA and
protein levels, as well as Hes1 and Hes5 mRNA levels (Figure 2B
and 2C), indicative of a significant repression in Notch signaling.
We next asked whether Prox1 directly interacts with the
chromatin of the proximal Notch1 gene promoter by performing
chromatin immunoprecipitation (ChIP) experiments (Figure 2D).
Author Summary
Early during development, neural progenitor cells (NPCs)
can either proliferate or differentiate into neurons. Thus,
generation of the correct number of neurons is governed
by a tightly regulated balance between proliferation and
differentiation, and disruption of this balance can result in
severe developmental deficits, malformations, or cancers.
Notch1 is a member of the Notch family of receptors,
which make up a highly conserved cell signaling system.
Notch1 signaling has been shown to inhibit NPC
differentiation and to promote self-renewal, thereby
allowing NPCs to divide and progressively generate the
enormous number of neurons present in the central
nervous system. The molecular mechanism by which NPCs
overcome Notch1-mediated inhibition in order to differ-
entiate into neurons, however, is not completely under-
stood. In this study, we show that Prox1, a homeobox
transcriptional repressor, plays a fundamental role in the
switch to differentiation by suppressing the expression of
Notch1 receptor, thereby preventing newly produced
neuronal precursors from receiving inhibitory signals from
Notch ligands present in neighboring cells. This transcrip-
tional repression may regulate cell cycle exit and
differentiation of NPCs as they migrate towards different
regions and adopt their final cell fates. We suggest that
Prox1 may exert its known influence on embryonic
development, organ morphogenesis, and cancer through
its ability to counteract Notch1 signaling.
Prox1 Suppresses Notch1 to Regulate Neurogenesis
PLoS Biology | www.plosbiology.org 2 December 2010 | Volume 8 | Issue 12 | e1000565Figure 1. Comparison of spatiotemporal expression patterns of Prox1, Notch1, and SCG10 genes in early embryonic chick spinal
cord. (A–I) Double in situ hybridizations with Notch1 (red) and SCG10 (blue) on sections from HH stages 18 (A–B), 24 (D–E), and 29 (G–H), and
comparison with Prox1 (C, F, and I) single in situ hybridizations on adjacent sections. The sections were from the thoracic level of spinal cord. (J–Q)
Double in situ hybridizations with Notch1 (red) and Prox1 (blue) on sections from HH stages 24 (J–K, thoracic level) and 29 (N–O, thoracic level), and
double in situ hybridizations with SCG10 (red) and Prox1 (blue) on sections from HH stages 24 (L–M, cervical level) and 29 (P–Q, thoracic level). Scale
bars: 100 mm. (R) Schematic representation of the Prox1 expression pattern in neural tube during early embryonic development.
doi:10.1371/journal.pbio.1000565.g001
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PLoS Biology | www.plosbiology.org 3 December 2010 | Volume 8 | Issue 12 | e1000565Figure 2. Prox1-mediated transcriptional repression of the Notch1 gene promoter in N2A cells is facilitated by NR5A2 and HDAC3.
(A) Transcriptional assays in N2A co-transfected with a Prox1 expression plasmid and luciferase reporter constructs containing human Notch1, mouse
Hes1, mouse Hes5, or human thymidine kinase promoters, as well as empty vector (PRless). In all luciferase experiments shown in this figure, data are
represented as the mean 6 SD of quadruplicate assays. In all cases p,0.01, except TK-Luc and PRless, p.0.1. (B–C) RT-PCR (B) and Western blot (C)
analysis of Prox1 overexpression in N2A, for Prox1, Notch1, Hes1, Hes5, and Gapdh genes (B), and Prox1, Notch1, and Actin proteins (C), as indicated.
(D) ChIP analysis of the binding of Prox1 to Notch1 promoter in N2A transiently transfected with a Prox1 construct or a control empty vector. The
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PLoS Biology | www.plosbiology.org 4 December 2010 | Volume 8 | Issue 12 | e1000565An antibody to Prox1 co-precipitated the proximal Notch1
promoter sequence in chromatin prepared from Prox1-transfected
cells, but not from mock-transfected N2A cells. In addition,
sequences from the distal 39-end of the Notch1 gene were not
precipitated with this antibody. Similarly, control IgGs were not
able to precipitate the proximal Notch1 promoter sequence, further
suggesting a direct interaction between Prox1 and chromatin from
Notch1 promoter.
To better understand the suppressive function of Prox1 on Notch1
promoter, different mutants of both Notch1 promoter construct and
Prox1 protein were constructed and utilized in luciferase assays.
We first identified on Notch1 promoter two overlapping consensus
binding sites for Prox1 [33], conserved between human, mouse,
and rat, located 597 bp upstream of the translation start site.
However, by mutating both of these sites (mut-N1-Luc) or deleting
a 426 bp sequence containing these sites (535-N1-Luc), we
observed that Prox1 is still sufficient to suppress Notch1 promoter
activity (Figure 2E). Furthermore, deletion of the DNA binding
domain (DBD) from the carboxy terminal of Prox1 protein was
not sufficient to relieve the Prox1-mediated suppression in Notch1
promoter activity (Figure 2E and Figure S2B), indicating that
Prox1 acts on Notch1 as transcriptional co-repressor via another
factor. There are two previously reported transcription factors that
utilize Prox1 as co-repressor via direct interactions to suppress
gene expression in other systems, NR5A2 (Nuclear Receptor 5A2)
and SF1 (Steroidogenic Factor 1), both belonging to the family of
orphan nuclear receptors [34–36]. NR5A2 is able to activate
Notch1-luc construct in N2A cells (Figure S2D) and is expressed in
the mammalian CNS (Figure 3B and Figure S3) [37]. Most
important, both wt Prox1 and DDBD-Prox1 are sufficient to
suppress the NR5A2-mediated induction of Notch1-luc construct
(Figure 2F). By performing ChIP experiments with the NR5A2
antibody on NR5A2-transfected and mock-transfected N2A cells,
we showed that NR5A2 specifically binds to the proximal Notch1
promoter sequence (Figure 2G), indicating that Prox1 is likely to
be recruited on the Notch1 promoter to suppress its activity via
direct interactions with NR5A2.
Moreover, by using a series of deletion mutants for the Prox1
protein in luciferase assays, we were able to map the repressive
function in the N-terminal domain (Figure 2H and Figure S2C). It
has been shown that Prox1 achieves its repressive action on gene
promoters via a previously described domain in the N-terminal
end of the protein, known as Repression Domain (RD) [35,38],
which is not involved in the direct interaction with the NR5A2
[35]. Deletion of this domain abolishes the ability of Prox1 to
suppress Notch1 promoter or the NR5A2-mediated induction of
Notch1-luc (Figure 2H and Figure S2E), and instead Prox1DRD is
now able to enhance Notch1 promoter activity (Figure 2H). It has
also been previously reported that the RD domain has a repressive
function on transcription by interacting and utilizing the activity of
Histone Deacetylase 3 (HDAC3) [35,38]. Consistently, treatment
of N2A cells with an HDAC inhibitor (trichostatin-A, TSA) is
sufficient to derepress endogenous Notch1 gene transcription and
Notch1-luc vector activity, as well as to abolish the Prox1-
mediated Notch1 suppression (Figure 2I and Figure S2F and S2G).
Moreover, HDAC3 over-expression suppresses Notch1 promoter
activity, which is further aggravated by Prox1 co-expression (Figure
2J), indicating that HDAC3 synergizes with Prox1 to suppress
Notch1 promoter. We then directly addressed whether Prox1
interacts with HDAC3 in the mouse CNS. First, by performing
RT-PCR, Western blot, and immunostainings, we showed that
HDAC3 is expressed in mouse embryonic spinal cord and mouse
NPCs isolated from the same tissue and cultured in vitro (Figure
S4 and unpublished data). In addition, a co-immunoprecipitation
assay showed that Prox1 could be co-precipitated with HDAC3
from protein extracts of mouse E12.5 CNS tissue (Figure 2K).
Moreover, by performing ChIP experiments with the HDAC3
antibody on HDAC3-transfected and mock-transfected N2A cells,
we showed that HDAC3 specifically binds to the proximal Notch1
promoter sequence (Figure 2L). These data indicate that
endogenous Prox1 and HDAC3 proteins indeed form a complex
in the developing mouse spinal cord and that Prox1 utilizes
HDAC3 inhibitory activity on transcription to suppress Notch1
gene expression.
Prox1 and NR5A2 Directly Interact with the Endogenous
Notch1 Promoter In Vivo
We next investigated whether physiological levels of endogenous
Prox1 and NR5A2 are sufficient to allow binding at the Notch1
promoter locus in vivo. Thus, by performing in vivo ChIP
experiments, we showed that endogenous Prox1 protein directly
interact with the Notch1 promoter locus in the mouse embryonic
CNS. In particular, an antibody to Prox1 co-precipitated the
proximal Notch1 promoter sequence, but not the 39 Notch1 coding
sequence, in chromatin prepared from E12.5 mouse CNS (Figure
3A). To address the same question for NR5A2, we first showed
that this gene is expressed in E12.5 mouse embryonic spinal cord
and NPCs isolated from the same tissue and cultured in vitro
(Figure 3B and Figure S3). Similar to Prox1 results, an antibody to
NR5A2 was sufficient to specifically precipitate the proximal
Notch1 promoter sequence in chromatin prepared from E12.5
mouse CNS (Figure 3C). Therefore we conclude that Prox1 and
NR5A2 specifically bind in vivo the Notch1 gene promoter.
We next tested whether Prox1 and NR5A2 could form a
complex on chromatin over the Notch1 promoter locus by
performing sequential ChIP assays (re-ChIP) in the mouse
embryonic CNS. In these experiments, Prox1, NR5A2, or control
organization of the Notch1 gene is schematically represented in the top panel. Exons are represented as black boxes. The primer pairs used to amplify
the corresponding DNA sequences are indicated with arrows below the schematic drawing. (E) Transcriptional assays in N2A co-transfected with WT
Prox1, DDBD Prox1, or empty vector, and WT Notch1-luc, mut-Notch1-Luc, or 535-Notch1-Luc reporter constructs. Schematic of the Notch1 promoter
and corresponding mutations are indicated in the top of the panel. In all cases p,0.01. (F) Transcriptional assays in N2A co-transfected with WT
Notch1-Luc construct and various combinations of expression vectors, as indicated. p,0.01 for NR5A2 alone versus NR5A2/Prox1, and NR5A2 alone
versus NR5A2/DDBD-Prox1. (G) ChIP analysis of the binding of NR5A2 to Notch1 promoter in N2A cells transfected with a NR5A2 construct or a
control empty vector. (H) Transcriptional assays in N2A co-transfected with Notch1-Luc construct and various deletion constructs for Prox1.
Schematic of the Prox1 deletion constructs is presented in the left of the panel. Grey box indicates the RD domain, and black box indicates the DBD
domain. In all cases p,0.01, except 331-Prox1 versus No-Prox1, p,0.05; 131-Prox1 versus No-Prox1, p.0.1. (I) RT-PCR analysis of Prox1
overexpression in N2A, treated with 150 nM TSA or vehicle alone, for endogenous Notch1 and Gapdh genes, as indicated. (J) Transcriptional assays in
N2A co-transfected with Notch1-Luc construct and HDAC3 expression vector in the presence or absence of Prox1. p,0.05 for WT versus HDAC3;
p,0.01 for WT versus HDAC3+Prox1; p,0.05 for HDAC alone versus HDAC3+Prox1. (K) Prox1 binds HDAC3 in vivo. Cell lysates from mouse
embryonic CNS (E12.5) were subjected to immunoprecipitations with anti-HDAC3 antibody, control anti-rabbit IgGs, or control anti-Brd2 antibody,
followed by immunoblotting with anti-Prox1 antibody. The positions of Prox1 and heavy chain of IgGs are shown on the left. (L) ChIP analysis of the
binding of HDAC3 to Notch1 promoter in N2A transfected with a HDAC3 construct or a control empty vector.
doi:10.1371/journal.pbio.1000565.g002
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PLoS Biology | www.plosbiology.org 5 December 2010 | Volume 8 | Issue 12 | e1000565Figure 3. Prox1 and NR5A2 interact in vivo with the promoter of Notch1 gene. (A) ChIP analysis of the binding of Prox1 to proximal Notch1
promoter in chromatin prepared from the CNS of E12.5 mouse embryos. The primer pairs used to amplify the corresponding DNA sequences are
indicated with arrows below the schematic drawing in Figure 2D. (B) RT-PCR analysis in NPCs cultured in vitro, and E12.5 mouse spinal cords, for the
detection of NR5A2 and Gapdh mRNAs, as indicated. (C) ChIP analysis of the binding of NR5A2 to proximal Notch1 promoter in chromatin prepared
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tion, was eluted from the protein A/G beads and subjected to a
second immunoprecipitation with antibodies recognizing NR5A2
or Prox1 in a crosswise manner. As shown in Figure 3D, re-ChIP
for NR5A2 following an initial ChIP for Prox1 generated specific
enrichment of the Notch1 promoter sequence, but not of the 39
Notch1 coding sequence or Notch1 promoter after initial ChIP with
control IgG. Reciprocal re-ChIP assays, in which the order of the
antibodies was inverted, generated identical results (Figure 3E).
These data together with the observation that Prox1 acts on Notch1
promoter as a co-repressor imply that the effect of Prox1 on Notch1
expression could be mediated through NR5A2.
Prox1 Enhances Neurogenesis and Inhibits Self-Renewal
and Astrogliogenesis in Mouse NPCs
To investigate whether the effect of Prox1 on Notch1 gene
expression is consistent with the function of Notch1 signaling in
self-renewal and differentiation of NPCs, we employed an in vitro
culture system using NPCs from embryonic mouse spinal cord,
which have the ability to self-renew and proliferate when cultured
in the presence of growth factors (GFs), as well as to differentiate
into neurons, astrocytes, and oligodendrocytes upon withdrawal of
GFs [39]. In these cultures, endogenous Prox1 is up-regulated upon
induction of differentiation at the mRNA level and a concomitant
induction in the number of Prox1+ cells is observed upon
withdrawal of GFs (Figure 4A–4E). In contrast, Notch1 mRNA
levels are reduced and inversely correlated with the induction of
Prox1 upon withdrawal of GFs (Figure 4E and 4F), supporting the
repressive action of Prox1 on Notch1 transcription. Interestingly, 2
d after in vitro differentiation, Prox1 is mainly expressed in the
majority of bIII-tubulin+ early differentiating neurons but also in a
fraction of nestin+ NPCs that remained undifferentiated (Figure
4G–4L). These Nestin+/Prox1+ cells may represent a transitory
cell population of intermediate precursors similar to the transitory
cell population observed in the intermediate zone of the chick and
mouse spinal cord (Figure 1 and Figure S1) [20,22]. Moreover,
Prox1 is also expressed in a subset of oligodendrocytes, although
the numbers of these cells are generally low in this experimental
system (Figure 4K and 4L). Most important, Prox1 is excluded
from GFAP+ astrocytes (Figure 4J and 4L), which is consistent
with the previously reported data that active Notch1 signaling is
required for the differentiation of astrocytes [2]. This suggests that
the absence of Prox1 expression in astrocytes may be required for
Notch1 receptor expression and astrocyte differentiation. This
observation could also explain the difference in slope between the
curves for Prox1 and Notch1 mRNA levels upon withdrawal of GFs
(solid lines in Figure 4E and 4F, respectively), since under these
conditions a significant number of astrocytes are generated that
express Notch1 but not Prox1 and contribute to mRNA levels.
Finally, in agreement with these in vitro differentiation assays, a
similar expression pattern for Prox1 was observed in vivo in
embryonic mouse spinal cord (Figure S5).
To further test Prox1 function, we transfected NPCs with
various constructs using the AMAXA electroporation system
(Figure S6) [39]. We first verified that Prox1 suppresses Notch1
transcription in these cells (Figure 5A and 5B). Similar to N2A
data, the NR5A2 was sufficient to induce Notch1 mRNA levels and
Notch1-luc activity, while Prox1 was able to inhibit this induction
(Figure 5C and 5D). To assess whether the inverse correlation
between Prox1 and Notch1 expression has functional importance,
we used NPCs as a model system to analyze the effect of Prox1
misexpression on Notch1-mediated self-renewal/proliferation
and/or differentiation of NPCs (Figure 4M) [2,40]. We first
examined the effect of Prox1 overexpression on NPC identity and
proliferation under conditions that favor self-renewal (+GFs)
(Figure S6). BrdU incorporation analysis 48 h after plating,
followed by 2 h of BrdU-pulse, revealed a strong reduction in
BrdU incorporation by 92.5% in a cell-autonomous manner
(Figure 5E–5G). Similarly, a dramatic decrease by 85% in the
proportion of Nestin+ cells was specifically observed in Prox1
transfected cells (Figure 5H–5J). Therefore, both indices show that
Prox1 negatively affects self-renewal and proliferation of NPCs,
with no indication of increased cell death as estimated by staining
for activated caspase 3 (unpublished data). We next asked whether
Prox1 overexpression also influences astrogliogenesis and neuro-
genesis. Under differentiation conditions, generation of astrocytes
was severely impaired (by ,90%) in the Prox1-electroporated
NPCs, as evidenced by measuring the index of GFAP+ cells
(Figure 5K–5M). Conversely, a significant increase in the
proportion of bIII-tubulin+ cells by ,3-fold was observed in the
Prox1 electroporated cells (Figure 5N–5P). Collectively our results
demonstrate that Prox1 through its action to negatively regulate
the expression of Notch1 is sufficient in a cell-autonomous manner
to arrest self-renewal of Nestin+ NPCs and enhance their
differentiation towards the acquisition of early bIII-tubulin+
neuronal identity, as opposed to depletion of GFAP+ astrocytes.
Ectopic Expression of Prox1 Suppresses Notch1 In Vivo to
Regulate Self-Renewal and Differentiation of NPCs
To further evaluate this conclusion in vivo, we misexpressed
Prox1 unilaterally in the neural tube by in ovo electroporation of
HH stage 12–14 (E2) chick embryos, following a previously
reported protocol [39]. A striking reduction in the expression of
Notch1 at the mRNA level was observed in the neural tube of
Prox1-electroporated embryos at both 24 h and 48 h after
electroporation (a. e.), as compared to control GFP-transfected
embryos (Figure 6A, 6B, 6E, 6F, 6I, and 6J). A concomitant
reduction in expression of the Notch1 target gene Hes5 was also
evident (Figure 6C, 6G, 6K, and 6Q), suggesting that Notch
signaling is counteracted by Prox1 in a cell-autonomous manner.
In addition, no evidence of apoptosis was observed either at 24 h
or later at 48 h a.e. (Figure S7A and unpublished data), excluding
the possibility that cells were depleted due to an apoptotic effect of
Prox1. To further test whether the Prox1-mediated effect on
Notch1 expression is responsible for Hes5 down-regulation, we co-
expressed together with Prox1 the constitutively active intracellu-
lar domain of mammalian Notch1 (NICD) (Figure S7B–S7D). Co-
expression of NICD was sufficient to rescue the negative effect of
Prox1 on Hes5 expression, excluding a direct action of Prox1 on
Hes5 transcription or another pathway (Figure 6M–6O and 6Q).
We have previously shown that forced depletion of Notch1 gene
expression in the VZ results in ectopic induction of neurogenesis
[39,41]. Similarly, misexpression of Prox1 caused ectopic neuronal
differentiation, as evidenced by induction of bIII-tubulin, an early
marker of post-mitotic neurons (Figure 6D, 6H, 6L, and 6R). This
observation has been previously reported by another group [20].
from the CNS of E12.5 mouse embryos. (D–E) Re-ChIP experiments were performed in the CNS of E12.5 mouse embryos on the Notch1 promoter (top
panels) and compared with the 39 Notch1 coding sequence (ORF, lower panels) using anti-Prox1, anti-NR5A2, or control antibodies in a serial manner.
The antibodies used in each round of precipitation are indicated in the top of each panel. The primer pairs used to amplify the corresponding DNA
sequences are indicated with arrows below the schematic drawing in Figure 2D.
doi:10.1371/journal.pbio.1000565.g003
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PLoS Biology | www.plosbiology.org 7 December 2010 | Volume 8 | Issue 12 | e1000565Figure 4. Prox1 is expressed in mouse NPCs cultured in vitro and up-regulated upon differentiation. (A–C) Double Prox1/Nestin
immunostainings of NPCs isolated from mouse spinal cords of E14.5 embryos, and cultured in vitro, either as neurospheres (A) or dissociated cells (B–
C), in the presence (A–B) or absence of GFs (C). Scale bar: 50 mm. (D) Quantification of Prox1+ cells in NPCs cultured in the presence (dotted line) or
absence (solid line) of GFs. The number of Prox1+ cells is expressed as percentage of the total number of DAPI+ cells. (E–F) Relative expression levels
of Prox1 (E) and Notch1 (F) mRNA in NPCs cultured in the presence (dotted line) or absence (solid line) of GFs, measured with quantitative real time
RT-PCR. (G–L) Double immunostainings of NPCs with Prox1 (green) and various markers (red), as indicated, cultured in the presence (G) or absence of
GFs (H–K). Scale bar: 50 mm. Quantification of Prox1+ (blue) or Prox12 (red) cells is shown in (L). (M) Schematic representation of the role of active
Notch signaling in regulating self-renewal and differentiation of NPCs.
doi:10.1371/journal.pbio.1000565.g004
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PLoS Biology | www.plosbiology.org 8 December 2010 | Volume 8 | Issue 12 | e1000565Figure 5. Forced expression of Prox1 in mouse NPCs suppresses progenitor identity, inhibits astrocyte differentiation, and induces
neurogenesis. (A–D) Relative luciferase activities (A and C) and mRNA levels (B and D) were measured in NPCs transfected with various constructs as
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PLoS Biology | www.plosbiology.org 9 December 2010 | Volume 8 | Issue 12 | e1000565However, here, we wanted to examine whether Prox1 achieves its
effect on neuronal differentiation via Notch1 gene suppression. To
this end, we again co-expressed NICD together with Prox1.
Interestingly, NICD strongly inhibited the Prox1-mediated
generation of ectopic bIII-tubulin+ neurons in the VZ (Figure
6P and 6R).
Figure 6. Misexpression of Prox1 in vivo suppresses Notch1 gene expression to induce early neuronal differentiation. (A–P) Double
GFP/bIII-tubulin immunostainings (A, D, E, H, I, L, M, and P) and in situ hybridizations for Notch1 (B, F, J, and N) and Hes5 (C, G, K, and O) in consecutive
sections, 24 h a. e. (A–D) or 48 h a.e. (E–P) with Prox1/GFP (A–H), GFP alone (I–L), or co-electroporation with Prox1/GFP and NICD (M–P). (D’), (H’), (L’),
and (P’) micrographs are larger magnifications of the white rectangle in (D), (H), (L), and (P), respectively. Scale bar: 50 mm. (Q) Quantitative analysis of
the Hes5+ area presented in (G), (K), and (O) using the ImageJ software. The data are presented as % of non-electroporated side. For Prox1 versus GFP
alone, p,0.01. For Prox1+NICD versus GFP alone, p,0.05. For Prox1+NICD versus Prox1, p,0.01. All cases referred to the electroporated side. (R)
Percentage of ectopic bIII-tubulin+ neurons per embryo (10 sections per embryo; n=4 embryos). The data are presented as % of Prox1
electroporated embryos. p,0.001 for Prox1 versus GFP; p,0.001 for Prox1 versus Prox1+NICD. (S–U) Double GFP/BrdU immunostainings 24 h a.e.
with Prox1/GFP (S), GFP alone (T), or co-electroporation with Prox1/GFP and NICD (U), followed by 2-h BrdU pulse. Scale bar: 50 mm. (V) Quantitative
analysis of BrdU incorporation. The number of BrdU+ transfected cells 24 h a.e. is expressed as percentage of the total number of transfected cells
(n=5 embryos; p,0.001 for Prox1 versus GFP; p,0.001 for Prox1 versus Prox1+NICD).
doi:10.1371/journal.pbio.1000565.g006
indicated. (E–G) Double GFP or Flag/BrdU immunostainings of NPCs in the presence of GFs and electroporated with GFP (E) or Prox1 (F) expression
vectors. In all panels of this figure, expression of transgenes was detected with anti-GFP or anti-Flag antibodies, respectively. Quantification of BrdU
index is shown in (G). p,0.001. (H–J) Double GFP or Flag/Nestin immunostainings of NPCs cultured in the presence of GFs and electroporated with
GFP (H) or Prox1 (I) expression vectors. Quantification of Nestin index is shown in (J) p,0.001. (K–M) Double GFP or Flag/GFAP immunostainings of
NPCs cultured in the absence of GFs and electroporated with GFP (K) or Prox1 (L) expression vectors. Quantification of GFAP index is shown in (M)
p,0.001. (N–P) Double GFP or Flag/bIII-tubulin immunostainings of NPCs cultured in the absence of GFs and electroporated with GFP (N) or Prox1 (O)
expression vectors. Quantification of bIII-tubulin index is shown in (P) p,0.01. For all panels scale bar: 50 mm.
doi:10.1371/journal.pbio.1000565.g005
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might affect self-renewal and proliferation of NPCs in the VZ. As
previously reported [20], a striking reduction in the number of
BrdU-incorporating cycling progenitors was observed in the
neural tube of Prox1-transfected embryos 24 h a.e. compared
with control GFP-transfected embryos (Figure 6S, 6T, and 6V).
Similar to neuron differentiation, we showed here that co-
expression of NICD abolishes the ability of Prox1 to arrest self-
renewal of NPCs (Figure 6U–6V), indicating that Prox1-mediated
suppression of Notch1 is essential for this function. In agreement,
it was previously shown that Prox1 misexpression in chick spinal
cord reduced the numbers of cycling Pax6+ and Pax7+ NPCs in
the VZ [20]. Taken together our results support the hypothesis
that Prox1 is involved in the transition of NPCs from self-renewal
to neuronal differentiation via direct regulation of Notch1.
Given the opposite functions of Prox1 and Notch1 in NPCs, we
then directlyaddressed thepossibilitythat Notch1antagonizesProx1
expression in a cross-inhibitory manner. To examine this, we first
used the c-secretase inhibitor DAPT in mouse NPCs. We verified
that this treatment inactivated Notch signaling, as evidenced with
reduced expression of Hes1 and Hes5genes (Figure 7A). Under these
conditions inhibition of Notch signaling caused a significant
induction in endogenous Prox1 mRNA expression by ,3-fold
(Figure 7B), suggesting that active Notch signaling in NPCs
suppresses Prox1 expression. Furthermore, when we misexpressed
NICD in chick neural tube, we observed that ectopic activation of
Notch1 signaling was sufficient to down-regulate endogenous
expression of Prox1 in vivo (Figure 7C–7H’). We conclude from
these experiments that a cross-inhibitory interaction between Prox1
and active Notch1 signaling regulates the expression of both genes.
The balance of this cross-inhibition might also regulate self-renewal
and differentiation of NPCs.
Prox1 Expression Is Necessary for Suppression of Notch1
In Vivo
We next examined the requirement of Prox1 for suppressing
Notch1 and thus regulating neurogenesis in vivo. To inhibit Prox1
expression in the chick neural tube, we utilized a pCAGGs-based
shRNA system fused with GFP reporter gene to follow the
expression of shRNAs (Figure S8A) [42,43]. The effective knock-
down of endogenous chick Prox1 in the neural tube was assessed in
mRNA and protein levels, by in situ hybridization and antibody
staining, respectively (Figure S8B, S8C, S8F, and S8G). In
addition, inhibition of endogenous Prox1 did not affect pro-
grammed cell death, as evidenced with TUNEL assay (Figure S8J).
Most important, knock-down of Prox1 clearly induced the
expression domain of Notch1 towards the MZ by 41.8%, as
compared to shControl (Figure 8A, 8B, and 8E). This induction
was accompanied by a concomitant induction in Hes5 gene
expression in a manner similar to the induction caused by
constitutively active NICD misexpression, indicative of ectopic
Notch signaling activation (Figure 8A–8C and 8F). Consistently,
expression of the proneural gene Cash1 was reduced in response to
Prox1 depletion in a similar manner to NICD overexpression,
indicative of enhanced Notch signaling that suppresses the initial
phases of neurogenesis (Figure 8G–8I).
To exclude off-target effects and assess the specificity of Prox1-
shRNA phenotypes, we performed two types of control experi-
ments. First, we electroporated a control shRNA construct,
containing a nucleotide sequence that does not target chick Prox1
and has no effect on chick Prox1 expression (Figure S8D, S8E,
S8H, and S8I). This control construct did not alter the expression
of Notch1, Hes5 (Figure 8B, 8E, and 8F), or Cash1 (Figure 8H).
Second, the Prox1-shRNA construct was co-electroporated with a
rescue construct containing the murine Prox1 coding sequence,
which is quite divergent from the chick sequence and therefore is
not targeted by the Prox1-shRNA sequence. A 6xHIS epitope tag
was also included to be able to follow its expression (Figure S9A–
S9C). Co-expression of murine Prox1 was sufficient to block the
Prox1-shRNA-mediated induction of Notch1 and Hes5, as well as
the suppression of Cash1 (Figure 8D, 8E, 8F, and 8J). Instead, it
was able to revert the Notch1 and Hes5 phenotypes by suppressing
the expression of both genes. Collectively, these lines of evidence
strongly support that depletion of endogenous Prox1 is responsible
for the effects observed on the expression of Notch1, Hes5, and
Cash1.
Furthermore, we addressed whether shRNA-mediated knock-
down of Prox1 affects the expression of other markers for NPCs.
Thus, we examined the expression of the homeodomain factors,
Pax7, Pax6, and Nkx2.2, which subdivide the VZ in the dorso-
ventral axis, into defined progenitor domains with restricted
developmental potentials. In each domain, whether dorsal or
ventral, an induction in the number of cells that express these
markers was observed in areas where Prox1-shRNA construct was
misexpressed (Figure S10). Conversely, it was previously shown
that forced Prox1 expression in chick spinal cord reduced the
number of Pax7+ and Pax6+ NPCs [20]. Interestingly, Prox1
knock-down expanded the expression of Pax7, Pax6, and Nkx2.2
in the medio-lateral axis, towards the MZ, without affecting their
dorso-lateral boundaries of expression. This suggests that Prox1
affects fundamental properties of NPCs relating to proliferation
versus differentiation decisions, without interfering with their sub-
type identity. In all cases overexpression of NICD phenocopied the
effect of Prox1 knock-down (Figure S10E–S10G, S10L–S10N, and
S10S–S10U), further suggesting that Prox1 is required for
suppression of NPC markers in spinal cord via inhibition of
Notch signaling.
These data indicate that Prox1-shRNA suppresses the initial
phases of neurogenesis. To evaluate this conclusion, we examined
expression of early and late markers of post-mitotic neurons,
namely bIII-tubulin and SCG10, respectively. Our analysis was
focused on dorsal interneurons, since Prox1 is mainly expressed in
interneuron precursors (Figure 1 and Figure S1) [20]. As expected,
Prox1 depletion strongly impaired neuronal differentiation by
,50% (Figure S11A, S11E, S11F, and S11J), while no effect was
seen in control shRNA transfected embryos (Figure S11B, S11E,
S11G, and S11J). As previously reported [44], we also showed that
NICD overexpression impaired neuronal differentiation, and thus
it is sufficient to recapitulate the effect of Prox1 ablation on
interneuron differentiation in spinal cord (Figure S11C, S11E,
S11H, and S11J). Moreover, co-expression of murine Prox1 with
shProx1 was able to rescue the negative effect on neurogenesis,
since the numbers of bIII-tubulin+ and SCG10+ cells were
restored (Figure S11D, S11E, S11I, and S11J). Taken together
these results suggest that Prox1 is necessary for proper regulation
of Notch1 gene expression, through which it controls induction of
interneuron differentiation.
Discussion
In contrast with the wealth of information on the role of Notch
signaling in neural development [1–3,45], little is known of the
upstream molecular mechanisms that control Notch1 gene
expression and regulate its inactivation in NPCs during neuronal
differentiation [10,46]. We show here that Prox1 directly interacts
with the chromatin over the Notch1 promoter in vivo, and
physiological levels of endogenous Prox1 are critical for the proper
regulation of Notch1 gene expression in vivo. In particular, this
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expression in the boundaries between VZ and MZ during the
neurogenic phase of vertebrate spinal cord development. This
repressive action is sufficient for proper regulation of cell cycle exit
and initiation of neuronal differentiation in NPCs, as evidenced by
induction of bIII-tubulin, an early marker for post-mitotic
neurons. In addition, Prox1 activity is necessary for suppression
of active Notch signaling, down-regulation of NPC markers, and
completion of neuronal differentiation program. We propose that
Prox1 is directly involved in the molecular mechanism that couples
and coordinates termination of Notch1 signaling with induction of
neuronal differentiation (Figure 8K). It was previously shown that
Notch1 signaling is modulated by a number of other mechanisms
such as glycosylation, differential trafficking, and ubiquitin-
dependent degradation of receptors and ligands, all of which play
important roles in CNS development [2,3,47,48]. However, as
early neuronal precursors begin to differentiate and migrate
outside the VZ, they cease to express Notch1 at the mRNA level
[11–13]. Thus, mechanisms that inhibit Notch1 receptor activity
via protein modifications and/or stability in neuronal precursors
Figure 7. Active Notch1 signaling suppresses Prox1 gene expression. (A–B) RT-PCR analysis of NPCs cultured in the presence or absence of
DAPT, for Hes1, Hes5, Gapdh (A), and Prox1 (B) genes, as indicated. For Prox1 mRNA, p,0.01, n=3. (C–H’) Double GFP/Prox1 immunostainings and in
situ hybridizations for Prox1 in consecutive sections, as indicated, 48 h a.e. with NICD/GFP (C–E’) or GFP alone (F–H’). (D’), (E’), (G’), and (H’)
micrographs are larger magnifications of the electroporated area in (D), (E), (G), and (H), respectively. Scale bar: 50 mm.
doi:10.1371/journal.pbio.1000565.g007
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whereas gene inactivation could act later in a more permanent
way when cells migrate out of the VZ. Consistently, Numb, which
acts as a Notch1 inhibitor via protein-protein interactions, begins
to be expressed in neuronal precursors while in the VZ [49–51],
whereas Prox1 is expressed later in the neuronal lineage when cells
withdraw from the cell cycle and exit the VZ [20,22,25,40].
Moreover, recent observations indicate that NPCs in the
undifferentiated/self-renewing state express Notch ligands, such
as Dll1, in an oscillatory manner [1], indicating that Notch ligands
are constantly available in the neuroepithelium. Thus, we suggest
that Prox1, by suppressing Notch1 gene expression, prevents newly
produced neuronal precursors from receiving signals from Notch
ligands present in the membrane of neighboring cells and allows
them to complete and sustain a neuronal differentiation program
(Figure 8K).
Consistently, Prox1 is induced by proneural genes and is
required for implementation of their neurogenic program
[20,22]. In particular, Prox1 is co-expressed with Mash1 and
Ngn2 in the subventricular zone of murine brain and chick spinal
cord during the initial stages of neurogenesis [20,22]. Overex-
pression of these factors in the chick spinal cord [20] or murine
NPCs is sufficient to induce Prox1 expression [22]. Conversely,
Prox1 levels are reduced in the embryonic brain of Mash1 knockout
mice [22], further suggesting that Prox1 expression during
neurogenesis is dependent on proneural genes. This epistatic
relationship between proneural genes and Prox1 may also explain
the inhibitory action of active Notch signaling on Prox1 expression
(Figure 7), since active Notch signaling directly suppresses the
expression of proneural genes [6,44], which then cannot induce
Prox1 (Figure 8K). In support, we were able to identify a number of
conserved E-box sequences on the Prox1 gene locus representing
putative proneural protein binding sites (Figure S12). However,
based on our data we cannot exclude the possibility of a direct
action of Notch signaling on Prox1 expression.
Moreover, this epistatic relationship could also explain how
proneural genes, after a certain number of oscillatory cycles of
expression, manage to overcome in a cell-autonomous manner the
Notch1-mediated inhibition on neurogenesis without depleting
NPCs [1]. In this regard, an intriguing question is why oscillations
of proneural genes, such as Ngn2, in NPCs are unable to induce
neuronal differentiation whereas their sustained expression does
elicit differentiation. It has been proposed that only a subset of
downstream genes, perhaps those already expressed in the VZ,
respond quickly to changes in proneural gene expression, whereas
genes expressed outside the VZ respond more slowly and cannot
be induced when Ngn2 expression oscillates [1]. Thus, Prox1 may
belong to these slowly responsive genes, induced upon sustained
Ngn2 expression to terminate Notch1 signaling and facilitate
neuronal differentiation. In this scenario, NPCs are not depleted
despite short pulses of Ngn2 expression but are maintained by
sustaining activated Notch signaling, which in turn prevents
neuronal differentiation.
Although Prox1 acts downstream of the bHLH proneural genes
[20] and is able to promote early neurogenic events, such as
ectopic inactivation of Notch signaling, cell cycle exit of NPCs, and
ectopic induction of bIII-tubulin+ cells in the VZ, it is not
sufficient to induce a full neurogenic expression program [20].
This observation suggests that Prox1 acts in concert with other
factors downstream of proneural proteins to induce neurogenesis
(Figure 8K). In agreement, proneural proteins are capable to
promote the expression of multiple downstream factors, such as
NeuroD, NeuroM, Nscl1, Delta1, Cend1, and Sox4/11, which are
involved in the implementation of a full neurogenic cascade
[5,39,52,53]. These factors are sufficient to induce a partial array
of neuronal specific phenotypes that can be fully achieved by
bHLH proneural factors. For example, Sox4/11 promote the
expression of specific neuronal markers, but they are not sufficient
to induce the exit of NPCs from the cell cycle or suppress
progenitor-specific gene expression [52]. Conversely, Prox1 is able
to achieve the latter but cannot fully phenocopy the effect of Sox4/
11 on inducing neuronal markers. Thus, proneural proteins
appear to activate multiple complementary downstream programs
to potentiate full neuronal differentiation. Moreover, genetic or
pharmacological inhibition of Notch signaling in chick neural tube
is sufficient to induce proneural gene expression, cause NPCs to
exit the cell cycle, downregulate progenitor identities, and induce a
full neurogenic expression program [44]. Although Prox1
misexpression in the same system is able to inhibit Notch
signaling, it cannot precisely mimic the effect of Notch inhibition
on terminal neuronal differentiation [20]. These observations
suggest that Prox1 exerts an extra action on NPCs, which is not
compatible with terminal neuronal differentiation in the spinal
cord. Consistently, endogenous Prox1 expression is downregulated
prior to acquisition of terminal neuronal identity in this region of
the CNS [20]. In addition to this function, Prox1 might be
involved in the specification of neuronal sub-types, since its
expression is excluded from the pMN domain (MN progenitors) of
the ventral spinal cord. In agreement, genetic inactivation of
Notch1 from NPCs of the ventral spinal cord suppresses MN
identity and induces V2 interneurons, suggesting that Notch1
activity is required for generation of MNs [54]. Thus, Prox1
exclusion from pMN could be associated with this requirement.
Furthermore, Prox1 is also expressed in several other regions of
the CNS, apart from the spinal cord, during embryonic and
postnatal stages of development, including the cortex, dentate
gyrus, thalamus, and cerebellum [21,55,56]. Interestingly, in adult
brain, Prox1 expression remains high in mature neurons of the
hippocampus and cerebellum [55]. This expression pattern is quite
distinct from the transient pattern of Prox1 expression in the
Figure 8. shRNA-mediated inhibition of Prox1 expression in chick spinal cord enhances expression of Notch1 and Hes5 genes and
impairs neurogenesis. (A–D) GFP/DAPI stainings and in situ hybridizations for Notch1 and Hes5 in consecutive sections 48 h a.e. with shProx1 (A),
shControl (B), NICD+GFP (C), or shProx1+mProx1 (D). (E–F) Quantitative analysis of the Notch1+ (E) and Hes5+ (F) areas presented in (A–D) using the
ImageJ software. The data are presented as % of non-electroporated side of the spinal cord. For Notch1+ area (E), shProx1 versus shControl, p,0.01;
shProx1 versus shProx1+mProx1, p,0.01, n=4 embryos. For Hes5+ area (F), shProx1 versus shControl, p,0.05; shProx1 versus NICD, p.0.1; shProx1
versus shProx1+mProx1, p,0.01, n=4 embryos. All cases referred to the electroporated side. (G–J) GFP/DAPI stainings and in situ hybridization for
Cash1 in consecutive sections 48 h a.e. with shProx1 (G), shControl (H), NICD/GFP (I), or shProx1+mProx1 (J). Scale bar: 100 mm. (K) Schematic
representation of the role of Prox1-mediated suppression of Notch1 expression in neuronal differentiation. During neurogenic phase of CNS
development, NPCs divide asymmetrically to produce one NPC and one neuronal precursor/nascent neuron. In NPC, active Notch1 signaling prevents
neuronal differentiation via direct inhibition of proneural genes. In nascent neurons, proneural genes activate Prox1 to suppress Notch1 gene
expression and thus prevent activation of Notch1 receptor from neighboring signal-sending cells and sustain the program for neuronal
differentiation. Moreover, Prox1-mediated inhibition of Notch1 may also block the inhibitory action of active Notch1 signaling on the expression of
proneural genes, thus generating a positive feedback loop to maintain proneural gene expression and further enhance neuronal differentiation.
doi:10.1371/journal.pbio.1000565.g008
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different in the developing or mature nervous system [55–57].
Given that Prox1 is a pleiotropic factor affecting many diverse
signaling pathways and transcriptional networks in other tissues
and organs [16,24,26,27,29,34,35,36], this differential expression
pattern may also imply a different mechanism of Prox1 action in
these regions of CNS. Therefore, based on our observations in the
embryonic spinal cord, we cannot rule out the possibility that
other signaling pathways may be involved in mediating the
function of Prox1 in other CNS regions independently of its ability
to counteract Notch1 in a cell-autonomous manner. In agreement,
it was recently published that ablation of Prox1 in postnatal dentate
gyrus leads to an increase in apoptosis of intermediate progenitors
and the absence of adult neurogenesis through a non-cell
autonomous mechanism [57].
A key question arising from our observations is whether other
Notch receptors (Notch2, 3, and 4) are implicated in the Prox1-
mediated inactivation of Notch signaling as documented by Hes5
gene down-regulation. Although, based on our data, we cannot
exclude a possible function of Prox1 in inhibiting other Notch
receptors, the fact that overexpression of the constitutively active
intracellular domain of Notch1 is sufficient to overcome the effect
of Prox1 on Hes5 gene down-regulation, cell-cycle exit, and ectopic
neuronal differentiation of NPCs suggests that these effects may be
achieved primarily through the Notch1 receptor. Moreover,
previous studies that report the phenotypes of Notch1, 2, 3, and 4
gene deletions in mouse embryos imply Notch1 as the most
important Notch receptor in CNS development and differentiation
[3]. Notch3 and Notch4 deletions do not affect neuronal differen-
tiation or CNS development [58–60]. On the other hand,
Notch2
2/2 embryos die around E11 and undergo massive cell
death in the CNS similar to Notch1
2/2 mice. However, they do not
show alterations in Hes5 expression in striking contrast to Notch1
2/2
mutants [61,62]. Consistently, Notch1 and Notch2 are differentially
expressed in mouse embryonic CNS [12,63].
Moreover, transcriptional assays in cell lines and NPCs indicate
that Prox1 acts as a transcriptional co-repressor in suppressing
Notch1 and its action may be mediated by NR5A2 and HDAC3
proteins that are co-expressed and interact with Prox1. We suggest
that these proteins facilitate Prox1 recruitment on Notch1
promoter and chromatin-mediated transcriptional repression,
respectively. Despite the fact that both proteins are expressed in
primary NPCs and embryonic mouse and chick CNS, their role in
CNS development is not known. Interestingly, the Prox1/NR5A2
complex, where Prox1 acts as a co-repressor, plays a crucial role in
the proper regulation of a set of genes, which are very important
for liver development, regeneration, and function
[27,35,36,64,65], suggesting that this role might have been
conserved in CNS development and function. In support of this
hypothesis, we showed here that physiological levels of endogenous
Prox1 and NR5A2 are sufficient to allow binding at the Notch1
promoter locus in the embryonic mouse CNS, and most
important, re-ChIP assays in the same tissue suggest that Prox1
and NR5A2 could form a complex on chromatin over the Notch1
promoter.
To conclude, in this study we have unveiled for the first time to
our knowledge a novel means of regulation of Notch signaling in
the developing spinal cord, which involves transcriptional
repression of Notch1 by Prox1. In addition, we have demonstrated
that this transcriptional repression has profound implications in
cell cycle exit and differentiation of neuronal precursors as they
exit the VZ and migrate towards the MZ to acquire terminally
differentiated phenotypes. This mechanism is of paramount
importance for generating the correct number of neurons from a
duly sustained pool of NPCs and we would like to propose that
part of the important roles of Prox1 in many different aspects of
embryonic development, organ morphogenesis, and cancer
pathogenesis [23,25–29,66] may be mediated through its ability
to counteract Notch signaling.
Materials and Methods
Ethics Statement
All animals were handled in strict accordance with good animal
practice as defined by the relevant European and Greek animal
welfare bodies.
RNA Extraction and Real-Time RT-PCR Analysis
Total RNA was isolated by using the RNAeasy Kit (Qiagen)
followed by treatment with RQ1 DNase. Quantitative real time
RT-PCR analysis was performed as described [39].
Primer sets used in RT-PCR assays:
mProx1-For: CAGCGGACTCTCTAGCACAG
mProx1-Rev: GCCTGCCAAAAGGGGAAAGA
mNotch1-For: GCCGCAAGAGGCTTGAGAT
mNotch1-Rev: GGAGTCCTGGCATCGTTGG
mHes1-For: TCAACACGACACCGGACAAACC
mHes1-Rev: GGTACTTCCCCAACACGCTCG
mHes5-For: CTCCGCTCCGCTCGCTAATCGC
mHes5-Rev: GCTTCATCTGCGTGTCGCTGGC
mNR5A2-For: TGAGTGGGCCAGGAGTAGTA
mNR5A2-Rev: ATCAAGAGCTCACTCCAGCA
mHDAC3-For: TATGCAGGGTTTCACCAAGA
mHDAC3-Rev: CAGAGATGCGCCTGTGTAAC
mGAPDH-For: AACTCCCTCAAGATTGTCAGCAA
mGAPDH-Rev: ATGTCAGATCCACAACGGATACA
Luciferase Assays
Transient transfections and luciferace reporter assays were
performed with Lipofectamine (Invitrogen) and luciferase/b-
galactosidase kits (Promega), respectively, as previously described
[67,68]. For Notch1-luc, Hes1-luc, Hes5-luc, and TK-luc
constructs we have used 0.4 mg per transfection and 1.6 mgo f
expression vectors (Prox1, NR5A2,o rHDAC3). All experiments
were done in quadruplicate at least three times, and statistical
analysis was performed by the paired two-sample Student’s t test.
Targeted Mutagenesis of the Notch1-Luciferase Promoter
Construct
To generate the mut-N1-Luc a PCR-based approach was used,
with the following primer sets:
N1promoter-EXT-For: AAGTAAGCTTCTTGGGGGAGC-
GGGGCACA
N1promoter-EXT -Rev: TCTTCCATGGGCCTCCCCACC-
GGCT
N1promoter-INT-For: CCGCCCCGGGATAATACGATTA-
TTCACATGCAAATTTCA
N1promoter-INT-Rev: ATGTGAATAATCGTATTATCCC-
GGGGCGGAATGGGGA
By this approach the two overlapping Prox1 consensus binding
sites [33] on Notch1 promoter were mutated from CTCCT-
CCGCT to ATAATACGAT.
To generate the 535-N1-Luc construct, a BamHI/NcoI
fragment from the WT Notch1-Luc construct was digested and
inserted into the parental pGL-2basic vector. All plasmid
constructs were verified with sequencing.
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ChIP assays were performed essentially as previously described
with minor modifications [69]. 10 to 25 mg of chromatin were used
per IP reaction with up to 3 mg of antibody. Chomatin-antibody
immunocomplexes were formed using affinity purified antibodies
to Prox1 (ReliaTech, 102-PA32), HDAC3 (Santa Cruz Biotech-
nology, SC-11417) [70], and NR5A2 (kindly provided by Dr
Talianidis) [71]. Antibody bound chromatin was retained on
protein A/G-magnetic beads (Invitrogen). DNA was extracted
from the immobilized bound immunocomplexes reversed, ethanol
precipitated, and analyzed by semi-quantitative PCR. The
following primer pairs were used to amplify the promoter and
ORF genomic loci from mouse Notch1 gene as indicated in Figure
2D:
N1-Promoter-5: AGTGCCTGGCCTCAATCCTCC (21 bp)
N1-Promoter-3: TGTAGCCGCCCTCTGCGACAT (21 bp)
N1-ORF-5: GCCAGTACAACCCACTACGG (20 bp)
N1-ORF-3: CACTGAGGTGTGGCTGTGAT (20 bp)
The re-ChIP experiments were performed as previously reported
[71]. Briefly, the immunocomplexes were pulled down with the first
antibody, treated with 20 mM DTT, followed by a 20-fold dilution
before performing the immunoprecipitation with the second
antibody. Cross-linking was reversed and DNA was purified and
subjected to PCR using the above mentioned primer sets.
Co-Immunoprecipitation Assay
Co-immunoprecipitation assays were performed from embry-
onic mouse CNS tissue (E12.5), including both brain and spinal
cord. Tissues were lysed in 20 mM Tris HCl (pH 7,5), 140 mM
NaCl, 1% Nonidet-P40, 2 mM EDTA, 1 mM Phenylmethylsul-
fonyl fluoride (PMSF), and cocktail inhibitors (SIGMA). The
following antibodies were used: anti-HDAC3 (Santa Cruz
Biotechnology, SC-11417) [70], anti-Brd2 (Santa Cruz Biotech-
nology, SC-46805), anti-Prox1 (Chemicon, Mab5654), and control
IgGs from DAKO. To retain antibodies protein-A agarose beads
were utilized (Pierce).
In Situ Hybridization on Cryosections
Non-radioactive in situ hybridization on cryosections and
preparations for digoxigenin- or fluorescein-labeled probes were
carried out as described [39,72].
Immunohistochemistry
Prox1 was detected using a rabbit polyclonal anti-Prox1
antibody (ReliaTech) or a mouse monoclonal antibody (Chemi-
con). Anti-BrdU monoclonal antibody was purchased from Dako
and detected as previously described [39]. Anti-Nestin and anti-
O4 monoclonal antibodies were from Chemicon; monoclonal
anti-GFAP was from Sigma; anti-activated caspase 3, anti-
HDAC3, anti-Brd2, and anti-Notch1 from Santa Cruz; and
monoclonal anti-bIII-tubulin was from Covance (USA). Anti-GFP
and anti-FLAG were purchased from Molecular Probes and
Sigma, respectively. Pax6, Pax7, and Nkx2.2 antibodies were
obtained from Developmental Studies Hybridoma Bank (Univer-
sity of Iowa, Iowa City). Detection of cells undergoing apoptosis on
sections was carried out with the TUNEL kit from Roche
(Mannheim, Germany) using Streptavidin Texas Red (Amer-
sham). Secondary antibodies conjugated with AlexaFluor 488
(green) or 546 (red) were from Molecular Probes. Cell nuclei were
labeled with Hoechst 33258 or DAPI (1:1000, Molecular Probes).
Specimens were viewed and analyzed with a Leica confocal
microscope. Statistical analysis was performed with the two-tailed
paired Student’s t test.
Culture of NPCs and Overexpression Studies
NPCs cultures from embryonic mouse spinal cords were
performed as previously described [39], with some modifications.
NPCs were prepared from E14.5 mouse embryo spinal cords and
maintained as neurosphere cultures in a serum-free medium [1:1
mixture of DMEM and F-12 with penicillin (100 units/ml;
Invitrogen) and streptomycin (100 mg/ml; Invitrogen)], containing
the B-27 supplement (1 ml/50 ml medium; Invitrogen), insulin (20
mg/ml; Sigma), recombinant human basic fibroblast growth factor
(bFGF 20 ng/ml; R&D Systems), and epidermal growth factor
(EGF 20 ng/ml; R&D Systems ). After 5–7 d in culture, floating
neurospheres were trypsin-dissociated and allowed to re-form
spheres at least three times before further use.
Proliferation studies were performed after dissociation to single
cells, plating onto poly-l-lysine coated coverslips in 24-well plates
at a density of 6610
4, and further culture for 2 d in the presence of
EGF/bFGF. For differentiation, dissociated neurospheres were
plated on poly-l-lysine-coated coverslips at a density of 7610
4and
maintained for 2 or 3 d in the absence of growth factors.
For Prox1 or GFP overexpression, cells were transfected using
an AMAXA electroporator (Lonza). The pCDNA3-Prox1 and
control GFP mammalian expression vectors were used, driving
transgene expression under the control of CMV promoter (5 mgo f
plasmid DNA per electroporation). Transfected neurospheres were
cultured for 24 h, after which, either they were enzymatically
dissociated and plated as single cells in poly-l-lysine-coated 10-
mm-diameter coverslips or they were cultured for a further 24 h
and collected for RNA extraction, luciferase assays, or Real-Time
RT-PCR analysis.
For quantification of proliferation, the index of BrdU+ cells was
determined by scoring the transgene (Prox1 or GFP) and BrdU
double-positive cells versus the total number of transgene positive
cells for each set of electroporations (Prox1 and GFP) from five
independent experiments. For quantification of differentiation, the
indices of Nestin+, bIII-tubulin+, GFAP+, and O4+ cells were
determined by scoring the transgene (Prox1 or GFP) and Nestin or
bIII-tubulin or GFAP or O4 double-positive cells versus the total
number of transgene positive cells for each set of electroporations
(Prox1 and GFP) from five independent experiments. Statistical
analysis was performed by the paired two-sample Student’s t test.
In Ovo Electroporation
Unilateral overexpression of transgenes and shRNA constructs
in the chick neural tube by in ovo electroporation method was
performed as previously described [39]. Briefly, white Leghorn
chicken eggs were incubated at 38 uC until stages 12–14 of
development (E2). Supercoiled plasmid for electroporation was
used at a concentration of 1–2 mg/ml in TE (10 mM Tris-HCl,
1 mM EDTA, pH 7.5) with 0.025% Fast Green (Sigma). Embryos
were injected with DNA solution into the lumen of the neural tube
and then subjected to electroporation. The electrodes were spaced
4 mm apart and positioned such that the DNA was driven into the
cells on only one side of the neural tube. Embryos were pulsed
263 times for 30 ms each at 28 V. Eggs were then re-incubated
for 1 or 2 d before the embryos were fixed for 4 h at 4 uCi n4 %
paraformaldehyde in PBS. Embryos were then washed in PBS,
cryoprotected with 20% sucrose, mounted in OCT (Tissue-Tek),
and sectioned at 12–14 mm. For BrdU-labeling, embryos received
10 mg BrdU in PBS 2 h before fixation. To distinguish the
expression of exogenous transgenes from that of the endogenous
genes, pCaggs based expression constructs were co-electroporated
alongside a GFP expression plasmid. To create pCAGGs-Prox1
and pCaggs-NICD expression vectors, the respective mouse and
human cDNAs were cloned into pCAGGS empty vector.
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we followed previously published methods [42,43]. In particular,
to generate the appropriate vectors we used the following primer
sets exactly as previously described [42]:
W: GGCGGGGCTAGCTGGAGAAGATGCCTTCCGGA-
GAGGTGCTGCTGAGCG
Y: GGGTGGCTTAAGAAGAGGGGAAGAAAGCTTCTA-
ACCCCGCTATTCACCACCACTAGGCA
Target: CTTCCTGGAAGAAGGCCATATA
RNAi-cProx1-B-For: GAGAGGTGCTGCTGAGCGATTC-
CTGGAAGAAGGCCATATATAGTGAAGCCACAGATGTA
RNAi-cProx1-B-Rev: ATTCACCACCACTAGGCACTTC-
CTGGAAGAAGGCCATATATACATCTGTGGCTTCACT
Target sequences on cProx1 were identified with a genescript
free online tool as described [42].
Supporting Information
Figure S1 Comparison of spatiotemporal expression
patterns of Prox1, Notch1, Hes5, and SCG10 in early
embryonic chick and mouse spinal cord. (A–P) Adjacent
transverse sections of HH stage 12 (A–D), HH stage 18 (E–H), HH
stage 24 (I–L), and HH stage 29 (M–P) cervical spinal cords were
hybridized with Prox1, Notch1, Hes5, and SCG10 riboprobes
(specific for chick), respectively, as indicated. Prox1 mRNA
expression is initiated after HH stage 12 (A) and remained until
HH stage 29 (E, I, and M). Note the inverse correlation between
Prox1 expression and Notch1, as well as Hes5 expression, in all
stages examined. Scale bars: 40 mm (A–L); 100 mm (M–P). (Q–T)
Horizontal section of mouse spinal cord were cut as indicated in
the schematic drawing in the left and were co-stained with anti-
Prox1 (red) and anti-Notch1 (green) antibodies in combination
with DAPI staining to reveal cell nuclei. Confocal analysis revealed
that the majority of cells do not co-express Prox1 and Notch1.
However, there are few cases that Prox1 and Notch1 are expressed
in the same cells (white arrows in T). The midline is indicated.
Scale bar: 50 mm.
Found at: doi:10.1371/journal.pbio.1000565.s001 (8.46 MB TIF)
Figure S2 Prox1-mediated transcriptional repression of
Notch1 gene promoter in N2A cells. (A) Transcriptional
assays in N2A cells co-transfected with Notch1-Luc construct and
human Prox1 expression construct or empty vector. Data are
represented as the mean 6 SD of quadruplicate assays (p,0.01).
(B) In the upper panel: Western blot analysis of WT Prox1 or
DDBD Prox1 overexpression in N2A cells. Both proteins are
tagged with the Flag epitope. Protein detection was performed
with an anti-Flag antibody and anti-Actin for loading control. In
the lower panel: anti-Flag (green) immunostainings of N2A cells
transfected with WT Prox1 or DDBD Prox1. Scale bar: 25 mm. (C)
In the upper panel: Western blot analysis of DRD Prox1, 331
Prox1, or 131 Prox1 overexpression in N2A cells, as indicated. All
proteins are tagged with the Flag epitope. Protein detection was
performed with an anti-Flag antibody. In the lower panel: anti-
Flag immunostainings of N2A cells transfected with the indicated
vectors. Scale bar: 25 mm. (D) Transcriptional assays in N2A cells
co-transfected with Notch1-Luc construct and either NR5A2 or
SF1 expression vectors, as indicated. Data are represented as the
mean 6 SD of quadruplicate assays. For WT versus NR5A2,
p,0.01; WT versus SF1, p,0.05. (E) Transcriptional assays in
N2A cells co-transfected with Notch1-Luc construct and NR5A2 in
the presence of either WT Prox1 or DRD Prox1. Data are
represented as the mean 6 SD of quadruplicate assays. For WT
versus NR5A2, p,0.01; WT versus NR5A2/Prox1, p.0.1; WT
versus NR5A2/DRD-Prox1, p,0.01; NR5A2/Prox1 versus
NR5A2/DRD-Prox1, p,0.01. (F) Transcriptional assays in N2A
cells transfected with Notch1-Luc and treated with either 150 nM
TSA or vehicle alone, as indicated. Data are represented as the
mean 6 SD of quadruplicate assays (p,0.001). (G) Transcrip-
tional assays in N2A cells co-transfected with Notch1-Luc and WT
Prox1 or DDBD Prox1 and treated with either 150 nM TSA or
vehicle alone, as indicated. Data are represented as the mean 6
SD of quadruplicate assays. For WT versus Prox1/TSA, p,0.01;
Prox1 versus Prox1/TSA, p,0.01; Prox1 versus DDBD-Prox1/
TSA, p,0.01.
Found at: doi:10.1371/journal.pbio.1000565.s002 (3.37 MB TIF)
Figure S3 Expression pattern of NR5A2 in embryonic
mouse spinal cord. (A–H) Transverse sections of E12.5 (A–D),
E14.5 (E–F), and E16.5 (G–H) embryonic mouse spinal cords were
co-stained with anti-NR5A2 and anti-bIII-tubulin (B, F, and H) or
anti-Nestin (D) antibodies, as indicated. (B’), (D’), (F’), and (H’)
micrographs are larger magnifications of the white rectangle in (B),
(D), (F), and (H), respectively. Arrows in (B’), (D’), (F’), and (H’)
indicate NR5A2+ cells that co-express bIII-tubulin (B’, F’, and H’)
or Nestin (D’). Note that NR5A2 expression is detected in bIII-
tubulin+ neurons of the mantle zone (A–B’, arrows in B’) and
Nestin+ NPCs of the ventricular zone (C–D’, arrows in D’). Scale
Bars: 100 mM (B, D, F, and H); 50 mM (B’, D’, F’, and H’).
Found at: doi:10.1371/journal.pbio.1000565.s003 (9.12 MB TIF)
Figure S4 Expression pattern of HDAC3 in embryonic
mouse spinal cord. (A) RT-PCR analysis in NPCs cultured in
vitro, and E12.5 mouse spinal cords, for the detection of Hdac3
and Gapdh mRNAs, as indicated. (B–E’) Transverse sections of
E10.5 (B–D’) and E12.5 (E–E’) embryonic mouse spinal cords
were co-stained with anti-HDAC3 and anti-Prox1 antibodies, as
indicated. (D’) and (E’) micrographs are larger magnifications of
the white rectangle in (D) and (E), respectively. Note that the
majority of Prox1+ cells express HDAC3. Arrows in (D’) and (E’)
indicate Prox1+ cells that co-express HDAC3. NPCs, neural
progenitor cells; SC, Spinal Cord; M, marker. Scale bar: 100 mM.
Found at: doi:10.1371/journal.pbio.1000565.s004 (9.48 MB TIF)
Figure S5 Expression pattern of Prox1 in embryonic
mouse spinal cord. (A–G) Transverse sections of E10.5 (A–B),
E12.5 (C–E), and E16.5 (F–G) embryonic mouse spinal cords were
co-stained with anti-Prox1 and anti-bIII-tubulin (A, C, and F) or
anti-Nestin (B and D) or anti-O4 (E) or anti-GFAP (G) antibodies,
as indicated. (A’), (B’), (C’), (D’), (F’), and (G’) micrographs are
larger magnifications of the white rectangle in (A), (B), (C), (D), (F),
and (G), respectively. Arrows in (A’), (B’), (C’), (D’), (E), and (F’)
indicate Prox1+ cells that co-express bIII-tubulin (A’, C’, and F’),
Nestin (B’ and D’), or O4 (E). Arrowheads in (A’), (B’), (D’), (E),
and (G’) indicate Prox1+ cells that are not positive for bIII-tubulin
(A’), Nestin (B’ and D’), O4 (E), and GFAP (G’). Note that Prox1 is
excluded from the GFAP+ astrocytes in E16.5 spinal cord (G–G’).
Scale Bars: 100 mM (A, B, C, D, F, and G); 50 mM (A’, B’, C’, D’,
F’, and G’).
Found at: doi:10.1371/journal.pbio.1000565.s005 (8.77 MB TIF)
Figure S6 Schematic representation of the protocol
used for AMAXA electroporation of NPCs. Neurosphere
cultures were passaged by enzymatic dissociation at least three
times before electroporation. After electroporation NPCs were
cultured for 24 h and then dissociated and plated in the presence
or absence of GFs for 48 h to immunostain them for various
markers and measure proliferation and differentiation indices. For
measuring mRNA or luciferase activity, cells were lysed 48 h after
electroporation and mRNA or protein extracts were prepared,
respectively.
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Figure S7 Quantification of Apoptosis in Prox1/GFP,
GFP alone, or Prox1/NICD co-electroporated embryos.
(A) Quantification of apoptosis in the electroporated and non-
electroporated sides of the spinal cord 24 h a.e. with Prox1/GFP,
GFP alone, or Prox1/GFP+NICD. Results are expressed as the
numbers of TUNEL+ cells per embryo in the transfected area and
compared with the TUNEL+ cells in the equivalent area of the
non-transfected side (eight sections per embryo; n=4 embryos; for
all three cases, p.0.1). (B) Schematic drawing for the Prox1 and
NICD expression constructs. (C–D) Double immunofluorescence
analysis of a transverse section of chick embryo spinal cord 48 h
a.e. with Prox1 and NICD, as indicated. Scale bar: 50 mm.
Found at: doi:10.1371/journal.pbio.1000565.s007 (3.73 MB TIF)
Figure S8 Identification of a shRNA construct efficient
in down-regulating endogenous Prox1 expression in
chick embryonic spinal cord. (A) Schematic representation
of the shRNA based constructs used in this study. GFP under the
control of chick b-actin promoter was also included to follow
expression of the shRNA. (B–E) GFP/DAPI stainings and in situ
hybridization for cProx1 gene in consecutive sections 48 h a.e. with
shProx1 (B–C) or shControl (D–E). (F–I) Double GFP/Prox1
immunostainings 48 h a.e. with shProx1 (F–G) or shControl (H–I).
Scale bar: 100 mm. (J) Quantification of apoptosis in the
electroporated and non-electroporated sides of the spinal cord
48 h a.e. with shProx1 or shControl. Results are expressed as the
numbers of TUNEL+ cells per embryo in the transfected area and
compared with the TUNEL+ cells in the equivalent area of the
non-transfected side (eight sections per embryo; n=4 embryos; for
both cases, p.0.1).
Found at: doi:10.1371/journal.pbio.1000565.s008 (9.03 MB TIF)
Figure S9 Rescue of the shRNA-Prox1 mediated pheno-
types by murine Prox1. (A) Schematic representation of the
shProx1 and murine Prox1 expression vectors. Note that shProx1
can be detected with GFP and murine Prox1 is tagged with 6xHIS
epitope, and thus can be detected with anti-HIS immunostaining.
(B–C) Double GFP/HIS immunostaining 48 h after co-electro-
poration of shProx1 and murine Prox1 constructs. Note that
murine Prox1 is distributed in the same cells as the shProx1
construct. Scale bar: 100 mm.
Found at: doi:10.1371/journal.pbio.1000565.s009 (4.11 MB TIF)
Figure S10 Prox1 is necessary for the suppression of
Pax7, Pax6, and Nkx2.2 expression in the chick embry-
onic spinal cord. (A–F) Double GFP/Pax7 immunostainings
48 h a.e. with shProx1 (A–B), shControl (C–D), or NICD/GFP
(E–F). The white lines indicate the outline of the spinal cord. (B’),
(D’), and (F’) micrographs are larger magnifications of the
electroporated area in (B), (D), and (F), respectively. Scale bar:
75 mm. (G) Quantitative analysis of the number of transfected cells
(GFP+) that are Pax7+ (white columns) or Pax7- (black columns).
The data are presented as % of the total number of transfected
cells (GFP+), n=4 embryos. For GFP+/Pax72, shProx1 versus
shControl, p,0.01; shControl versus NICD/GFP, p,0.01;
shProx1 versus NICD/GFP, p.0.1. (H–M) Double GFP/Pax6
immunostainings 48 h a.e. with shProx1 (H–I), shControl (J–K), or
NICD/GFP (L–L’). The white lines indicate the outline of the
spinal cord. (I’), (K’), and (M’) micrographs are larger magnifica-
tions of the electroporated area in (I), (K), and (M), respectively.
Scale bar: 75 mm. (N) Quantitative analysis of the number of
transfected cells (GFP+) that are Pax6+ (white columns) or Pax62
(black columns). The data are presented as % of the total number
of transfected cells (GFP+), n=4 embryos. For GFP+/Pax62,
shProx1 versus shControl, p,0.01; shControl versus NICD/GFP,
p,0.01; shProx1 versus NICD/GFP, p.0.1. (O–T) Double GFP/
Nkx2.2 immunostainings 48 h a.e. with shProx1 (O–P), shControl
(Q–R), or NICD/GFP (S–T). Scale bar: 50 mm. (U) Quantitative
analysis of the number of Nkx2.2+ cells presented in (O–T). The
data are presented as % of non-electroporated side of the spinal
cord. For shProx1 versus shControl, p,0.05; shControl versus
NICD/GFP, p,0.05; shProx1 versus NICD/GFP, p.0.1, n=4
embryos. All cases referred to the electroporated side. (V–W)
Endogenous Prox1 is expressed in a subset of Nkx2.2+ cells in the
ventral spinal cord. Double Prox1/Nkx2.2 immunostainings in
transverse sections of wild type embryonic chick spinal cord of HH
stage 24. Scale bar: 50 mm.
Found at: doi:10.1371/journal.pbio.1000565.s010 (9.97 MB TIF)
Figure S11 shRNA-mediated inhibition of Prox1 expres-
sion in chick spinal cord impairs neurogenesis. (A–D)
Double GFP/bIII-tubulin immunostainings 48 h a.e. with
shProx1 (A), shControl (B), NICD+GFP (C), or shProx1+mProx1
(D). Scale bar: 100 mm. (E) Quantitative analysis of the bIII-
tubulin+ areas presented in (A–D) using the ImageJ software. The
data are presented as % of non-electroporated side of the spinal
cord. shProx1 versus shControl, p,0.01; shControl versus NICD,
p,0.01; shProx1 versus NICD, p.0.1; shProx1 versus
shProx1+mProx1, p,0.01, n=4 embryos. All cases referred to
the electroporated side. (F–I) GFP/DAPI stainings and in situ
hybridization for SCG10 in consecutive sections 48 h a.e. with
shProx1 (F), shControl (G), NICD+GFP (H), or shProx1+mProx1
(I). Scale bar: 100 mm. (J) Quantitative analysis of the SCG10+
area presented in (F–I) using the ImageJ software. The data are
presented as % of non-electroporated side of the spinal cord.
shProx1 versus shControl, p,0.01; shControl versus NICD,
p,0.01; shProx1 versus NICD, p.0.1; shProx1 versus
shProx1+mProx1, p,0.01, n=4 embryos. All cases referred to
the electroporated side.
Found at: doi:10.1371/journal.pbio.1000565.s011 (8.59 MB TIF)
Figure S12 Schematic representation of the conserved
binding sites (E-boxes) for proneural proteins on the
mouse Prox1 gene locus. (A–B) 168 kb of the mouse Prox1
gene locus (100 kb upstream and 20 kb downstream of the Prox1
gene, chromosome 1: from 192094506 to 191926560) were
aligned with the corresponding area of the human genome and
the conserved binding sites for proneural proteins were identified
as indicated (red lines). This analysis was performed with the ECR
Browser software tool, freely available at http://ecrbrowser.dcode.
org. Nine conserved putative binding sites were identified, based
on the E-box consensus sequence, as previously published
(CANNTG) [5,53]. Detailed description of the orientation,
position, and sequence of each site is indicated in (B).
Found at: doi:10.1371/journal.pbio.1000565.s012 (1.86 MB TIF)
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